NCT07213830
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07213830
Title A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor Therapies
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Ipsen
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | FRA | ESP | CAN

Facility Status City State Zip Country Details
START MidWest PI Sharma RECRUITING Grand Rapids Michigan 49546 United States Details
Sarah Cannon Research Institute PI McKean Nasville, TN, USA NOT_YET_RECRUITING Nashville Tennessee 37205 United States Details
MD Anderson PI Champiat NOT_YET_RECRUITING Houston Texas 77030 United States Details
Start San Antonio PI Rasco RECRUITING San Antonio Texas 78229 United States Details
NEXT PI Spira NOT_YET_RECRUITING Fairfax Virginia 22031 United States Details
Princess Margaret Cancer Center PI Spreafico NOT_YET_RECRUITING Toronto Canada Details
Gustave Roussy Cancer Campus Grand Paris- (Institut de Cancerologie Gustave-Roussy) - PI Ronan NOT_YET_RECRUITING Villejuif France Details
Hospital Universitario Vall d'Hebron PI Garralda Cabanas NOT_YET_RECRUITING Barcelona Spain Details
NEXT Quiron-Barcelona - PI Saavedra Santa Gadea NOT_YET_RECRUITING Barcelona Spain Details
START Madrid - CIOCC. Grupo Hospital de Madrid (HM) - Centro Integral Oncologico Clara Campal (CIOCC) - Calvo Aller NOT_YET_RECRUITING Madrid Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field